Advanced search
Publication Cover
Leukemia & Lymphoma Volume 60, 2019 - Issue 13
Submit an article Journal homepage
312
Views
7
CrossRef citations to date
0
Altmetric
Commentaries

Chronic lymphocytic leukemia, skin and other second cancers

Stephen P. MulliganDepartment of Haematology, Royal North Shore Hospital, St Leonards, Sydney, Australia; ;Royal North Shore Hospital, Joint CLL Dermatology and Oncology Clinic, St Leonards, Sydney, Australia; Correspondence[email protected]
,
Stephen ShumackRoyal North Shore Hospital, Joint CLL Dermatology and Oncology Clinic, St Leonards, Sydney, Australia; ;Department of Dermatology, Royal North Shore Hospital, St Leonards, Sydney, Australia;
&
Alexander GuminskiRoyal North Shore Hospital, Joint CLL Dermatology and Oncology Clinic, St Leonards, Sydney, Australia; ;Department of Medical Oncology, Royal North Shore Hospital, St Leonards, Sydney, Australia
Pages 3104-3106 | Received 17 Aug 2019, Accepted 04 Sep 2019, Published online: 24 Sep 2019

References

  • Dighiero G, Maloum K, Desablens B, et al. Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia. N Engl J Med. 1998; 338(21): 1506–1514.
  • Crassini KR, Best OG, Mulligan SP. Immune failure, infection and survival in chronic lymphocytic leukemia. Haematologica. 2018;103(7):e329.
  • Velez NF, Karia PS, Vartanov AR, et al. Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia. JAMA Dermatol. 2014;150(3):280–287.
  • Ishdorj G, Beiggi S, Nugent Z, et al. Risk factors for skin cancer and solid tumors in newly diagnosed patients with chronic lymphocytic leukemia and the impact of skin surveillance on survival. Leuk Lymphoma. 2019:1–10.
  • Manusow D, Weinerman BH. Subsequent neoplasia in chronic lymphocytic leukemia. JAMA. 1975;232(3):267–269.
  • Gunz FW, Angus HB. Leukemia and cancer in the same patient. Cancer. 1965;18:145–152.
  • Hock BD, McIntosh ND, McKenzie JL, et al. Incidence of cutaneous squamous cell carcinoma in a New Zealand population of chronic lymphocytic leukaemia patients. Intern Med J. 2016;46(12):1414–1421.
  • Royle JA, Baade PD, Joske D, et al. Second cancer incidence and cancer mortality among chronic lymphocytic leukaemia patients: a population-based study. Br J Cancer. 2011;105(7):1076–1081.
  • Gies P, van Deventer E, Green AC, et al. Review of the Global Solar UV Index 2015 Workshop Report. Health Phys. 2018;114(1):84–90.
  • Mulcahy A, Mulligan SP, Shumack SP. Recommendations for skin cancer monitoring for patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2018;59(3):578–582.
  • World Health Organisation (WHO). International Agency for Research on Cancer. Global Cancer Observatory [cited 2019 Aug 1]. Available from: http://gco.iarc.fr/today/data/factsheets/cancers/17-Non-melanoma-skin-cancer-fact-sheet.pdf.
  • Zheng G, Chattopadhyay S, Sud A, et al. Second primary cancers in patients with acute lymphoblastic, chronic lymphocytic and hairy cell leukaemia. Br J Haematol. 2019;185(2):232–239.
  • Tomaszewski JM, Gavriel H, Link E, et al. Aggressive behavior of cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia. Laryngoscope. 2014;124(9):2043–2048.
  • Tsimberidou AM, Wen S, McLaughlin P, et al. Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma. J Clin Oncol. 2009;27(6):904–910.
  • Bloom R, Amber KT, Nouri K. An increased risk of non-Hodgkin lymphoma and chronic lymphocytic leukemia in US patients with Merkel cell carcinoma versus Australian patients: a clinical clue to a different mechanism of pathogenesis? Australas J Dermatol. 2016;57(3):e114–e116.
  • Trizuljak J, Srovnal J, Plevova K, et al. Analysis of prognostic significance of merkel cell polyomavirus in chronic lymphocytic leukemia. Clin Lymphoma Myeloma Leuk. 2015;15(7): 439–442.
  • Hisada M, Biggar RJ, Greene MH, et al. Solid tumors after chronic lymphocytic leukemia. Blood. 2001;98(6):1979–1981.
  • Benjamini O, Jain P, Trinh L, et al. Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: distribution and clinical outcomes. Leuk Lymphoma. 2015;56(6):1643–1650.
  • Falchi L, Vitale C, Keating MJ, et al. Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia. Ann Oncol. 2016;27(6):1100–1106.
  • Maurer C, Langerbeins P, Bahlo J, et al. Effect of first-line treatment on second primary malignancies and Richter's transformation in patients with CLL. Leukemia. 2016;30:2019–2025.
  • Byrd JC, Hillmen P, O'Brien S, et al. Long-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab. Blood. 2019;133(19):2031–2042.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.